B. Braun Executive and Leadership Team

Sri Sulistiowati, the Chief Financial Officer at B. Braun, directs the global fiscal strategy and capital allocation processes for the organization. Overseeing the integrity of financial reporting, the Chief Financial Officer ensures compliance with international accounting standards while supporting the expansion of medical device manufacturing capabilities. This leadership role involves analyzing market trends to optimize resource distribution across the diverse portfolio of infusion therapy and surgical instruments. By implementing robust risk management frameworks, Sri Sulistiowati directly impacts the long-term financial health of the company. Furthermore, the Chief Financial Officer collaborates with regional leadership to align budgetary goals with the overarching mission of providing high-quality pharmaceutical solutions. Through precise fiscal planning, Sulistiowati secures the necessary investment for research and development, ultimately driving sustainable growth and operational efficiency within the competitive global healthcare landscape.

Scott Farrell, the Group Chief Financial Officer at B. Braun, manages the consolidated financial performance and corporate investment strategy for the multinational entity. Coordinating with the board, the Group Chief Financial Officer evaluates large-scale acquisitions and divestitures to strengthen the market position in dialysis and hospital pharmacy solutions. This role requires deep oversight of global liquidity and currency hedging strategies to mitigate risks inherent in operating across 60 countries. Scott Farrell maintains rigorous control over the capital structure, ensuring that the organization possesses the financial agility to innovate within the medical technology sector. By fostering transparency in financial communications, the Group Chief Financial Officer builds trust with stakeholders and investors. Ultimately, Farrell optimizes the balance sheet to support the continuous development of life-saving medical products, ensuring that the company remains a leader in the global healthcare industry through disciplined fiscal management.

Yazmin Ruiz, the Chief Financial Officer (Mexico) at B. Braun, oversees all financial operations and regional fiscal planning within the Mexican market. Managing local tax compliance and regulatory reporting, the Chief Financial Officer (Mexico) ensures that the regional business unit maintains profitability while delivering essential medical products to local healthcare providers. This leadership role involves coordinating with supply chain teams to optimize inventory costs for surgical instruments and wound care solutions. Yazmin Ruiz drives initiatives to improve cash flow management and operational efficiency across the regional footprint. By analyzing local market dynamics, the Chief Financial Officer (Mexico) provides actionable insights that inform strategic decision-making for the broader Latin American operations. Through diligent oversight of regional budgets, Ruiz supports the expansion of service offerings, ensuring that the company meets the specific needs of the healthcare sector while maintaining strict adherence to corporate financial standards.

Muhammad Arqam, the Chief Financial Officer & Head of Strategic Accounts Management at B. Braun, integrates financial oversight with the development of high-value client relationships. Directing the strategy for key hospital partnerships, the Chief Financial Officer & Head of Strategic Accounts Management ensures that service contracts for infusion therapy and dialysis solutions remain both profitable and mutually beneficial. This dual-focused role involves negotiating complex agreements while maintaining strict budgetary discipline across the strategic accounts portfolio. Muhammad Arqam analyzes revenue streams to identify opportunities for cross-selling the broad range of medical products and services. By aligning financial incentives with client needs, the Chief Financial Officer & Head of Strategic Accounts Management drives long-term revenue growth and market penetration. Through this strategic approach, Arqam strengthens the company's competitive advantage, ensuring that the organization delivers consistent value to major healthcare institutions while achieving robust financial performance targets.

Punrada Lertkomonsuk, the Chief Financial Officer, B Braun Ltd (Thailand) at B. Braun, manages the financial health and operational accounting for the Thai subsidiary. Overseeing local financial planning and analysis, the Chief Financial Officer, B Braun Ltd (Thailand) ensures that the regional business unit effectively allocates resources to support the distribution of medical devices and pharmaceutical solutions. This leadership role involves navigating local regulatory environments and optimizing the cost structure for regional logistics. Punrada Lertkomonsuk drives improvements in financial reporting accuracy and internal controls to support the company's growth objectives in Southeast Asia. By collaborating with regional sales teams, the Chief Financial Officer, B Braun Ltd (Thailand) ensures that pricing strategies remain competitive while protecting profit margins. Through meticulous fiscal oversight, Lertkomonsuk enables the organization to maintain a strong market presence, ensuring that the company continues to provide high-quality medical care to patients across the region.

Thomas Whalen, the Interim Chief Financial Officer (North America) at B. Braun, directs the financial operations and strategic planning for the North American market. Managing the regional budget and financial forecasting, the Interim Chief Financial Officer (North America) ensures that the organization maintains fiscal stability while scaling operations for medical products and services. This leadership role involves overseeing financial audits and ensuring compliance with regional regulatory requirements. Thomas Whalen collaborates with the executive team to identify cost-saving opportunities and improve operational efficiency across the North American supply chain. By providing clear financial guidance, the Interim Chief Financial Officer (North America) supports the successful execution of regional business strategies. Through proactive management of financial risks, Whalen ensures that the company remains well-positioned to meet the evolving demands of the healthcare industry, ultimately contributing to the overall success and growth of the organization in this critical market.

Cristian Vacarezza, the Principal Chief Financial Officer at B. Braun, provides high-level financial leadership and oversight for the company's global manufacturing and pharmaceutical divisions. Directing the development of long-term financial models, the Principal Chief Financial Officer ensures that the organization maintains the capital strength required for continuous innovation in medical technology. This role involves coordinating with global department heads to align financial performance with the company's strategic goals for infusion therapy and surgical instruments. Cristian Vacarezza evaluates the financial impact of new product launches and market expansions, ensuring that investments yield sustainable returns. By implementing advanced financial analytics, the Principal Chief Financial Officer enhances the accuracy of corporate forecasting and decision-making. Through this strategic leadership, Vacarezza supports the company's mission to improve patient outcomes, ensuring that the organization remains financially resilient and capable of delivering high-quality medical solutions on a global scale.

Kikoo Tejwani, the President at B. Braun, directs the overall strategic vision and business execution for the organization. Leading the executive team, the President ensures that the company's mission to improve patient outcomes remains the central focus of all operations, from manufacturing to market distribution. This leadership role involves setting the long-term growth strategy and overseeing the expansion of the company's presence in key global markets. Kikoo Tejwani fosters a culture of innovation and excellence, encouraging the development of new medical products and pharmaceutical solutions that address unmet healthcare needs. By engaging with stakeholders and industry partners, the President strengthens the company's market position and reputation for quality. Through decisive leadership, Tejwani guides the organization through complex industry challenges, ensuring that the company continues to deliver value to patients and healthcare providers while maintaining its status as a leader in the global medical devices and pharmaceutical sector.

Mor Vamos, the Chief Operations Officer at B. Braun, directs the global manufacturing and supply chain operations for the company's extensive medical product portfolio. Overseeing the production of infusion therapy systems and surgical instruments, the Chief Operations Officer ensures that manufacturing processes meet the highest standards of quality and safety. This leadership role involves optimizing the global logistics network to ensure the timely delivery of pharmaceutical solutions to hospitals and clinics worldwide. Mor Vamos drives continuous improvement initiatives to enhance production efficiency and reduce waste across all manufacturing facilities. By collaborating with the research and development teams, the Chief Operations Officer ensures that new products are scalable and ready for mass production. Through rigorous operational oversight, Vamos maintains the company's reputation for excellence, ensuring that the organization consistently meets the complex demands of the global healthcare market while maintaining high levels of operational performance.

Paul Alderete, the Chief Administrative Officer at B. Braun, manages the internal infrastructure and corporate services that support the company's global operations. Directing human resources, facilities management, and corporate communications, the Chief Administrative Officer ensures that the organization maintains a productive and compliant work environment. This leadership role involves implementing policies that foster innovation and support the professional development of the workforce across 60 countries. Paul Alderete oversees the integration of administrative systems to improve cross-departmental collaboration and operational efficiency. By streamlining internal processes, the Chief Administrative Officer enables the company to focus on its core mission of developing and marketing medical products. Through effective management of corporate resources, Alderete ensures that the organization remains agile and responsive to the needs of the healthcare industry, ultimately supporting the company's long-term success and commitment to improving patient care through a strong and well-supported internal foundation.